Published in Am J Pathol on March 01, 2002
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Calcification of myocardial necrosis is common in mice. Virchows Arch (2005) 1.08
A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am J Pathol (2004) 0.98
Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy. Mol Cell Biochem (2008) 0.94
Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage. Cardiovasc Diabetol (2010) 0.92
Desmin filaments influence myofilament spacing and lateral compliance of slow skeletal muscle fibers. Biophys J (2004) 0.90
Μyospryn: a multifunctional desmin-associated protein. Histochem Cell Biol (2013) 0.89
Cardiac dysfunction in aging conscious rats: altered cardiac cytoskeletal proteins as a potential mechanism. Am J Physiol Heart Circ Physiol (2008) 0.86
A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization. FASEB J (2008) 0.86
Osteopontin: At the cross-roads of myocyte survival and myocardial function. Life Sci (2014) 0.82
Fabrication of cell-laden macroporous biodegradable hydrogels with tunable porosities and pore sizes. Tissue Eng Part C Methods (2014) 0.78
Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival. J Cell Sci (2016) 0.77
Mitochondrial control of cell death. Nat Med (2000) 9.17
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature (1997) 7.10
Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol (1997) 6.42
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem (1998) 4.86
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl (1995) 3.52
Altered patterns of gene expression in response to myocardial infarction. Circ Res (2000) 2.76
Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation (1999) 2.59
Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A (2000) 2.59
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol (1996) 2.44
Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem (1988) 2.28
Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol (2000) 2.24
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet (1998) 2.17
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res (1999) 2.11
Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J (1994) 2.04
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med (2000) 2.04
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell (1992) 2.00
Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol (2001) 1.95
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A (2000) 1.93
Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol (1992) 1.89
Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol (1996) 1.80
Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol (1994) 1.74
Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem (1991) 1.65
Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer (1998) 1.64
Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol (2000) 1.64
A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci U S A (1998) 1.61
Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest (1994) 1.50
Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol (1999) 1.48
Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol (1997) 1.44
Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol (1999) 1.42
Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol (1993) 1.40
Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem (1989) 1.34
Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest (1999) 1.28
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest (1996) 1.27
Osteopontin-induced modifications of cellular functions. Ann N Y Acad Sci (1995) 1.26
The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol (1999) 1.22
Identification of genes regulated during mechanical load-induced cardiac hypertrophy. J Mol Cell Cardiol (2000) 1.21
Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem (1999) 1.20
Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics (2000) 1.18
Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol (2001) 1.17
Molecular analysis of intermediate filament cytoskeleton--a putative load-bearing structure. Am J Physiol (1984) 1.16
Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation (1997) 1.15
Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences. Am J Pathol (1978) 1.12
Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res (2000) 1.07
A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet (1999) 1.07
Myocardial fibre calcification. J Clin Pathol (1981) 1.07
Myocardial osteopontin expression coincides with the development of heart failure. Hypertension (1999) 1.04
Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin. J Biol Chem (1997) 1.04
Incidence of cardiac and other soft tissue mineralized lesions in DNA-2 mice. Lab Anim Sci (1972) 0.98
Calcium-binding properties of osteopontin derived from non-osteogenic sources. J Biochem (1993) 0.95
Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J Physiol (1994) 0.95
The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J (1993) 0.92
Detection of mouse osteopontin by western blotting. Biochem Biophys Res Commun (1998) 0.87
Noncollagenous matrix proteins controlling mineralization; possible role in pathologic calcification of vascular tissue. Trends Cardiovasc Med (1998) 0.86
Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation (1995) 0.86
Ultrastructural changes in inherited cardiac calcinosis of DBA/2 mice. Am J Vet Res (1987) 0.85
Desmin cytoskeleton in healthy and failing heart. Heart Fail Rev (2000) 0.83
A computer-driven approach to PCR-based differential screening, alternative to differential display. Bioinformatics (1999) 0.78
Nitric oxide and its congeners in mitochondria: implications for apoptosis. Environ Health Perspect (1998) 0.77
Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med (2003) 2.91
Structural and functional roles of desmin in mouse skeletal muscle during passive deformation. Biophys J (2004) 1.31
Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. Proc Natl Acad Sci U S A (2004) 1.29
Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J Biol Chem (2002) 1.15
Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres. Mol Biol Cell (2002) 1.05
Costameres: repeating structures at the sarcolemma of skeletal muscle. Clin Orthop Relat Res (2002) 0.99
Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin. J Biol Chem (2007) 0.97
Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure. J Cell Biol (2008) 0.96
Evidence for increased myofibrillar mobility in desmin-null mouse skeletal muscle. J Exp Biol (2002) 0.96
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance. J Appl Physiol (1985) (2003) 0.93
Alterations in the heart mitochondrial proteome in a desmin null heart failure model. J Mol Cell Cardiol (2005) 0.92
Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur Heart J (2011) 0.92
Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study. Eur J Clin Invest (2010) 0.89
Μyospryn: a multifunctional desmin-associated protein. Histochem Cell Biol (2013) 0.89
A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization. FASEB J (2008) 0.86
Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement. J Mol Cell Cardiol (2004) 0.83
Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. Basic Res Cardiol (2015) 0.81
Amino-terminally truncated desmin rescues fusion of des(-/-) myoblasts but negatively affects cardiomyogenesis and smooth muscle development. FEBS Lett (2002) 0.79
Desmin modulates lung elastic recoil and airway responsiveness. Am J Physiol Lung Cell Mol Physiol (2005) 0.78